NasdaqGS - Nasdaq Real Time Price • USD
Kura Oncology, Inc. (KURA)
As of 12:45 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 13 | 13 |
| Avg. Estimate | -0.55 | -0.56 | -2.32 | -2.46 |
| Low Estimate | -0.68 | -0.68 | -2.92 | -3.1 |
| High Estimate | -0.44 | -0.51 | -2 | -1.94 |
| Year Ago EPS | -0.5 | -0.53 | -2.08 | -2.32 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 12 | 12 |
| Avg. Estimate | -- | -- | -- | 14.07M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 49.34M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.54 | -0.55 | -0.55 | -0.55 |
| EPS Actual | -0.5 | -0.53 | -0.5 | -0.55 |
| Difference | 0.04 | 0.02 | 0.05 | 0 |
| Surprise % | 7.40% | 3.60% | 9.10% | 0.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.55 | -0.56 | -2.32 | -2.46 |
| 7 Days Ago | -0.55 | -0.56 | -2.32 | -2.46 |
| 30 Days Ago | -0.55 | -0.56 | -2.32 | -2.46 |
| 60 Days Ago | -0.54 | -0.54 | -2.22 | -2.34 |
| 90 Days Ago | -0.58 | -0.61 | -2.26 | -1.75 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | KURA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -10.00% | -- | -- | 1.30% |
| Next Qtr. | -5.70% | -- | -- | 10.60% |
| Current Year | -11.50% | -- | -- | 5.10% |
| Next Year | -6.00% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 19.93% | -- | -- | 11.21% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/22/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/28/2024 |
| Reiterates | Wedbush: Outperform to Outperform | 2/28/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 1/31/2024 |
| Initiated | Mizuho: Buy | 12/22/2023 |
Related Tickers
SNDX Syndax Pharmaceuticals, Inc.
21.26
+1.41%
CGEM Cullinan Therapeutics, Inc.
16.08
+2.89%
BCYC Bicycle Therapeutics plc
22.88
+1.37%
SWTX SpringWorks Therapeutics, Inc.
45.97
+7.18%
RNA Avidity Biosciences, Inc.
25.46
+5.37%
IMVT Immunovant, Inc.
29.30
+1.95%
RVMD Revolution Medicines, Inc.
36.63
+0.54%
YMAB Y-mAbs Therapeutics, Inc.
16.15
+6.53%
TCRX TScan Therapeutics, Inc.
7.26
+1.97%
JANX Janux Therapeutics, Inc.
49.89
+2.07%